Update on NAV and Anthropic valuation

Summary by AI ^BETAClose X

Schiehallion Fund Limited announced an upward adjustment to the valuation of its Anthropic holding, which has increased its proportion of total assets to 7.2% as of April 24, 2026, up from 3.2% on March 31, 2026. This revaluation has contributed to the company's Net Asset Value reaching 191.47 cents at the close of business on April 24, 2026.

Disclaimer*

Schiehallion Fund Limited (The)

27 April 2026

This announcement contains inside information for the purposes of Article 7 of the UK Market Abuse Regulation. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

The Schiehallion Fund Limited

("The Company")

Legal Entity Identifier: 213800NQOLJA1JCWXQ56

Update on Net Asset Value and adjustment to the valuation of Anthropic

Today, the Board has been advised by the Manager of an upwards adjustment in the valuation of the Company's holding in Anthropic in line with its policy for valuing private company investments. This has been reflected in the Net Asset Value of the Company which as at close of business on 24 April 2026 stands at 191.47 cents.

Following that adjustment in valuation the proportion of the Company's total assets made up by Anthropic stands at 7.2% at close of business on 24 April 2026, compared with 3.2% on 31 March 2026.

Baillie Gifford & Co Limited

27 April 2026

Regulated Information Classification: Additional regulated information required to be disclosed under applicable laws and regulations.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END